Source: Tengion, Inc.
Date: May 19, 2008
Summary:
Tengion, Inc., a clinical stage biotechnology company focused on the development of neo-organs and neo-vessels, presented preclinical efficacy data for its Tengion Neo-Bladder Replacement™ at the Annual Meeting of the American Urological Association (AUA) in Orlando, Florida on May 18, 2008.
